As previously reported by Brookfield Brief, Pfizer was looking to acquire the biotech company Seagen Inc. to further the company's capabilities in cancer treatment.

Five weeks into his job as the new CEO as Novavax, John Jacobs raised the possibility on Tuesday afternoon that the company may not survive 2023.

Pfizer is looking to further expand its global prominence as the company has now set its eyes on acquiring Seagen Inc. which would further Pfizer’s capabilities within cancer therapies.

The United States government has agreed to purchase another 1.5 million Covid-19 vaccines from the company Novavax Inc.

CVS is close to an agreement to acquire Oak Street Health for about $10.5 billion including debt, a deal that would rapidly expand the big healthcare company’s footprint of primary-care doctors with a large network of senior-focused clinics.

It has been a rough start to the year for electric van manufacturer Arrival as the UK-based company announced it will cut jobs to reduce costs.

General Electric will start 2023 by splitting off its healthcare unit, completing a key step in the slow-motion breakup of the industrial giant. For the rest of the year it will face questions about the next big step: shedding its power businesses.

Walgreens-backed VillageMD has agreed to buy urgent care provider Summit Health in a deal valued at nearly $9 billion.

Pfizer CEO Albert Bourla laid out his plan Tuesday to keep the pharmaceutical giant growing through 2030, as the Covid-19 pandemic fades and the company faces generic competition for some of its blockbuster drugs.

Amazon is looking to expand further into the healthcare industry as the company has made a bid to secure Signify Health Inc., an in-home health service provider that could be valued at as much as $8 billion.

After Pfizer’s dominant global success with the Covid-19 vaccine the U.S.-based company has continued to expand outward by purchasing an 8.1% stake, worth roughly $95 million in the French vaccine company Valneva as the two companies work to develop a Lyme disease vaccine.

Vaccinations appear to be all the rage when it comes to mitigating the severity of the Covic-19 pandemic, however, a biotechnology company known as AstraZeneca has been furthering advancements in Covid-19 treatment that the company says can reduce the development of severe Covid symptoms and even deaths by 50%

The first drug showing promise to slow Alzheimer’s disease was approved by U.S. health regulators after years of research and billions of dollars in investment.The United States Food and Drug Administration said it approved the Biogen created drug, which has the molecular name aducanumab and will be sold as Aduhelm, based on evidence it reduces a sticky substance in the brain called amyloid that is associated with Alzheimer’s

A recent breakthrough in cancer treatment occurred Friday when Amgen Inc.’s new drug known as Lumakras was approved by the Food and Drug Administration. Amgen Inc.’s new drug Lumakras is designed to treat a mutation of lung cancer known as KRAS. This mutation is the most common among lung cancers and previously was believed to be untreatable by the use of drugs

As COVID-19 vaccinations are spreading around the world, limitations on travel have continued to weaken. Countries such as Italy, Iceland, Greece and Spain have already begun to allow for international travel with proof of COVID-19 vaccinations, however, governments and airlines are now discussing what methods should be used to prove that a traveler has immunity to the virus

Walmart continued its expansion into the healthcare realm when on Thursday the company purchased the telehealth provider MeMD and plans to offer virtual healthcare services to customers and employees. Walmart’s plan to expand into the virtual healthcare market is in response to Amazon beginning to offer health care services to employees through their platform known as Amazon Care

05.05.20 - U.S. regulators and state officials are finding that a significant number of imported N95-style masks are falling short of certification standards, complicating the response to the coronavirus crisis and potentially putting some front-line workers at greater risk

03.16.20 - According to the Associated Press, the first US human clinical trial of a potential vaccine for the new coronavirus will begin Monday. The trial, which will test the effects of an experimental vaccine shot developed by the National Institutes of Health and drug maker Moderna, won’t make use of either an active or inactive sample of the virus, as is common for vaccines, but will instead use a gene-based method that uses messenger RNA to trigger an immune response in the target individual

03.16.20 - If this crisis has exposed anything, it is how imperative it is that we keep pharmaceutical supply chains within our own borders. We have laws that prevent the manufacturing of our defensive equipment and weapons outside of our borders for the sake of national security. These laws need to extend to medical devices and pharmaceuticals, as this extends to national security our public health is national security

02.17.20 - A Pennsylvania based biotech company Inovio Pharmaceuticals says it created a coronavirus vaccine three hours after getting access to the virus' genetic sequence on Jan. 9 in it’s San Deigo laboratory, and now scientists are racing to get the vaccine on the market in record time